This article is more than 5 years old. Information may no longer be current.

Abbott receives US marketing approval for next-generation contact lens solution

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

ABBOTT PARK, Ill. — The U.S. Food and Drug Administration has granted market clearance to Abbott Medical Optics for its RevitaLens Ocutec multipurpose disinfecting solution for silicone hydrogel and conventional soft contact lenses, AMO announced.

The comprehensive, next-generation solution — which has already received a European CE mark — is designed to kill microorganisms, remove protein deposits from lenses, decrease corneal staining and minimize eye complications.

"Proper contact lens care, including a rub and rinse regimen using RevitaLens Ocutec, will help patients achieve clean and comfortable lenses while enhancing overall lens-wearing satisfaction," Jim Mazzo, senior vice president for AMO, said in the release.

The company plans to begin shipping RevitaLens Ocutec multipurpose disinfecting solution in the U.S. this month.